Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Precision Health Database


Precision Health Database|Search|PHGKB

Heart, Lung, Blood and Sleep Disorders

Last data update: Sep 29, 2023. (Total: 61661 Documents since 2012)
   dataset      
Filtered By:

Previous    

Records 1 - 30 (of 74 Records)

Next

Query Trace: all[original query]>>Ethical, Legal and Social Issues (ELSI)[Category]
Legal aspects of genetic testing in the evaluation of ventricular tachycardias.
Regina Duryagina et al. Herzschrittmacherther Elektrophysiol 2023
Experimental drugs in clinical trials for COPD: Artificial Intelligence via Machine Learning approach to predict the successful advance from early-stage development to approval.
Luigino Calzetta et al. Expert Opin Investig Drugs 2023
CRISPR in Public Health: The Health Equity Implications and Role of Community in Gene-Editing Research and Applications.
Andrew M Subica et al. Am J Public Health 2023 e1-e9
Genetic Testing in Patients With Congenital Heart Disease: You Do No Harm When Using the Right Tools!
Julie De Backer et al. Circulation. Genomic and precision medicine 2023 e004104
Ethical layering in AI-driven polygenic risk scores-New complexities, new challenges.
Marie-Christine Fritzsche et al. Frontiers in genetics 2023 141098439
The ethics of gene therapy for hemophilia: a narrative review.
Lieke Baas et al. Journal of thrombosis and haemostasis : JTH 2023
Ethical Perspectives of Therapeutic Human Genome Editing From Multiple and Diverse Viewpoints: A Scoping Review.
Joseph Andrew M et al. Cureus 2022 14(11) e31927
Public willingness to participate in population DNA screening in Australia.
Tiller Jane M et al. Journal of medical genetics 2022
Population genomic screening: Ethical considerations to guide age at implementation.
Spencer Scott J et al. Frontiers in genetics 2022 13899648
Ethics of digital therapeutics (DTx).
Refolo P et al. European review for medical and pharmacological sciences 2022 26(18) 6418-6423
The current status and future of FDA-approved artificial intelligence tools in chest radiology in the United States.
Milam M E et al. Clinical radiology 2022
The controversial embryo tests that promise a better baby Some companies offer tests that rank embryos based on their risk of developing complex diseases such as schizophrenia or heart disease. Are they accurate — or ethical?
M Koslov, Nature, September 21, 2022
Artificial Intelligence-Augmented Propensity Score, Cost Effectiveness and Computational Ethical Analysis of Cardiac Arrest and Active Cancer with Novel Mortality Predictive Score.
Monlezun Dominique J et al. Medicina (Kaunas, Lithuania) 2022 58(8)
Legal Implications of Stroke Biobanking and Genomics Research in Sub-Saharan Africa.
Adigun Muyiwa et al. Journal of law and medicine 2022 29(2) 579-598
The 2021 landscape of FDA-approved artificial intelligence/machine learning-enabled medical devices: An analysis of the characteristics and intended use.
Zhu Simeng et al. International journal of medical informatics 2022 165104828
Capacity-Building for Stroke Genomic Research Data Collection: The African Neurobiobank Ethical, Legal, and Social Implications Project Experience.
Uvere Ezinne O et al. Biopreservation and biobanking 2022
Communal Coping as a Strategy to Enhance Family Engagement in Dilated Cardiomyopathy.
Burke Wylie et al. Circulation. Genomic and precision medicine 2022 101161CIRCGEN121003541
The impact of FDA and EMA regulatory decision-making process on the access to CFTR modulators for the treatment of cystic fibrosis.
Costa Enrico et al. Orphanet journal of rare diseases 2022 17(1) 188
Is the world ready for gene therapy?
Garrison Louis P et al. Haemophilia : the official journal of the World Federation of Hemophilia 2022 28 Suppl 25-8
Symbolic Legislation and the Regulation of Stroke Biobanking and Genomics Research in Sub-Saharan Africa.
Adigun Muyiwa et al. The theory and practice of legislation 2022 9(3) 404-424
Need for Racial and Ethnic Diversity in Asthma Precision Medicine.
González Burchard Esteban et al. The New England journal of medicine 2021 385(24) 2297-2298
Ethical dilemma: ELX/TEZ/IVA or Lung Transplantation in Cystic Fibrosis and End Stage Lung Disease?
Breuer Oded et al. Chest 2021
Unraveling the Ethical, Legal, and Social Implications of Neurobiobanking and Stroke Genomic Research in Africa: A Study Protocol of the African Neurobiobank for Precision Stroke Medicine ELSI Project.
Akinyemi Rufus O et al. International journal of qualitative methods 2020 19
Using Artificial Intelligence for High-Volume Identification of Silicosis and Tuberculosis: A Bio-Ethics Approach.
Spiegel Jerry M et al. Annals of global health 2021 87(1) 58
Professionally responsible management of the ethical and social challenges of antenatal screening and diagnosis of β-thalassemia in a high-risk population.
Corda Valentina et al. Journal of perinatal medicine 2021
An Integrated Review of Hypertrophic Cardiomyopathy in Black Populations: Underrecognized and Understudied.
Arabadjian Milla et al. The Journal of cardiovascular nursing 36(2) 104-115
Constructing a Bioethical Framework to Evaluate and Optimise Newborn Bloodspot Screening for Cystic Fibrosis.
Armstrong Rachael E et al. International journal of neonatal screening 2020 May 6(2)
Health data research on sudden cardiac arrest: perspectives of survivors and their next-of-kin.
Bak Marieke A R et al. BMC medical ethics 2021 Jan 22(1) 7
Organoids for personalized treatment of Cystic Fibrosis: Professional perspectives on the ethics and governance of organoid biobanking.
Lensink Michael A et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 Dec
Feasibility and acceptability of early infant screening for sickle cell disease in Lagos, Nigeria-A pilot study.
Oluwole Esther O et al. PloS one 2020 15(12) e0242861
TOP